What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Virus
Andrew J. Pollard mainly investigates Immunology, Vaccination, Virology, Meningococcal disease and Neisseria meningitidis.
In his study, Gastroenterology and Typhoid fever is strongly linked to Internal medicine, which falls under the umbrella field of Immunology.
His Vaccination study incorporates themes from Reactogenicity, Immunogenicity and Polysaccharide Vaccine.
His study in Virology is interdisciplinary in nature, drawing from both Humoral immunity, Antibody, Antigen and Priming.
Andrew J. Pollard has researched Meningococcal disease in several fields, including Intensive care, Disease, Meningococcal vaccine and Conjugate vaccine.
His work investigates the relationship between Neisseria meningitidis and topics such as Bacterial disease that intersect with problems in Serotype.
His most cited work include:
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)
- Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. (299 citations)
What are the main themes of his work throughout his whole career to date?
Andrew J. Pollard mostly deals with Immunology, Vaccination, Virology, Pediatrics and Antibody.
Immunology and Neisseria meningitidis are frequently intertwined in his study.
His Neisseria meningitidis research includes themes of Meningitis and Microbiology.
His research investigates the connection between Vaccination and topics such as Immunogenicity that intersect with issues in Pneumococcal conjugate vaccine.
Many of his research projects under Virology are closely connected to Conjugate with Conjugate, tying the diverse disciplines of science together.
His Meningococcal disease research is multidisciplinary, relying on both Disease and Outbreak.
He most often published in these fields:
- Immunology (39.72%)
- Vaccination (28.95%)
- Virology (24.76%)
What were the highlights of his more recent work (between 2018-2021)?
- Vaccination (28.95%)
- Immunology (39.72%)
- Typhoid fever (13.99%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Vaccination, Immunology, Typhoid fever, Internal medicine and Clinical trial.
His Vaccination study is concerned with the larger field of Virology.
The concepts of his Virology study are interwoven with issues in Monoclonal antibody and Coronavirus disease 2019.
His Immunology study frequently draws connections between adjacent fields such as Disease.
His biological study spans a wide range of topics, including Conjugate vaccine and Environmental health.
His work carried out in the field of Clinical trial brings together such families of science as Pandemic and Intensive care medicine.
Between 2018 and 2021, his most popular works were:
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. (190 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Virus
The scientist’s investigation covers issues in Vaccination, Internal medicine, Immunology, Clinical trial and Vaccine efficacy.
His Vaccination study combines topics from a wide range of disciplines, such as Booster dose, Antibody, Immunization, Immunogenicity and Transmission.
As a member of one scientific family, Andrew J. Pollard mostly works in the field of Transmission, focusing on Titer and, on occasion, Conjugate vaccine.
His Immune system, Immunity, Toxoid and Antigen investigations are all subjects of Immunology research.
His Clinical trial study integrates concerns from other disciplines, such as Viral Vaccine and Intensive care medicine.
The various areas that Andrew J. Pollard examines in his Reactogenicity study include Young adult and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
